Literature DB >> 12914332

[Advances of pharmacological effects of triterpenes from Ganoderma lucidum].

Jun Luo1, Zhi-bin Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12914332

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN： 0513-4870


× No keyword cloud information.
  7 in total

1.  Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry.

Authors:  Min Yang; Xiaoming Wang; Shuhong Guan; Jiameng Xia; Jianghao Sun; Hui Guo; De-An Guo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-26       Impact factor: 3.109

2.  Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer.

Authors:  Faisal F Y Radwan; J Manuel Perez; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2011-12-11

3.  Deep insight into the Ganoderma lucidum by comprehensive analysis of its transcriptome.

Authors:  Guo-Jun Yu; Man Wang; Jie Huang; Ya-Lin Yin; Yi-Jie Chen; Shuai Jiang; Yan-Xia Jin; Xian-Qing Lan; Barry Hon Cheung Wong; Yi Liang; Hui Sun
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

4.  Triterpenoids from the spores of Ganoderma lucidum.

Authors:  Bingji Ma; Wei Ren; Yan Zhou; Jinchuan Ma; Yuan Ruan; Chun-Nan Wen
Journal:  N Am J Med Sci       Date:  2011-11

5.  Ganoderic acid A inhibits proliferation and invasion, and promotes apoptosis in human hepatocellular carcinoma cells.

Authors:  Xu Wang; Di Sun; Jiandong Tai; Lei Wang
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

6.  Effect of Ganoderma lucidum Powder on Oxidative Stability, Microbial and Sensory Properties of Emulsion Type Sausage.

Authors:  Runak Ghobadi; Rasoul Mohammadi; Javaher Chabavizade; Masoud Sami
Journal:  Adv Biomed Res       Date:  2018-02-16

Review 7.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.